Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton

被引:27
作者
ReyesMoreno, C [1 ]
Koutsilieris, M [1 ]
机构
[1] CHUL, MOL ENDOCRINOL LAB, RES CTR, ST FOY, PQ G1V 4G2, CANADA
关键词
insulin-like growth factor I; osteoblastic metastasis; prostate cancer; transforming growth factor beta 1; urokinase-type plasminogen activator;
D O I
10.1023/A:1018413229570
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We analysed the glucocorticoid receptor (GR) function and its ability to modulate cell-cell interactions between the PA-m rat prostate cancer and UMR 106 osteoblast-like rat osteosarcoma cells as an in vitro model for studying GR function in PA-III cell-induced tumor and blastic reaction in rat bone, Intact GR was detected by ligand binding assays, DNA band-shift, and GR trans-activation analysis of PA-III and UMR 106 cells transiently transfected with the mouse mammary tumor, virus thymidine kinase-chloramphenicol acetyltransferase reporter gene, Dexamethasone and transforming growth factor beta 1 (TGF beta 1) inhibited the growth of PA-III and UMR 106 cells, Dexamethasone's inhibition of PA-III and UMR 106 cells was reversed by anti-TGF beta 1 antibody and exogenous insulin-like growth factor I (IGF-I), Exogenous IGF-I, urokinase-type plasminogen activator (uPA), UMR 106 conditioned media (CM) and PA-III CM stimulated the proliferation of PA-III and UMR 106 cells, The mitogenic activity exerted by uPA and PA-III CM in UMR 106 cells was completely neutralized by anti-IGF-I specific antibody, In addition, dexamethasone up-regulated TGF beta 1 mRNA and do,vn-regulated uPA mRNA expression in PA-III cells without affecting TGF beta 1 and uPA mRNA expression in UMR 106 cells, These data suggested that TGF beta 1, uPA, and IGF-I mediate at least in part cell-cell interactions and GR function in PA-III prostate cancer and UMR 106 osteosarcoma cells.
引用
收藏
页码:205 / 217
页数:13
相关论文
共 47 条
  • [1] THE CELL BIOLOGY OF TRANSFORMING GROWTH-FACTOR-BETA
    BARNARD, JA
    LYONS, RM
    MOSES, HL
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1032 (01) : 79 - 87
  • [2] MEDIATION OF GLUCOCORTICOID RECEPTOR FUNCTION BY THE ACTIVATION OF LATENT TRANSFORMING GROWTH-FACTOR-BETA-1 IN MG-63 HUMAN OSTEOSARCOMA CELLS
    BOULANGER, J
    REYESMORENO, C
    KOUTSILIERIS, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (05) : 692 - 697
  • [3] INVOLVEMENT OF THE PLASMIN SYSTEM IN DISSOCIATION OF THE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN COMPLEX
    CAMPBELL, PG
    NOVAK, JF
    YANOSICK, TB
    MCMASTER, JH
    [J]. ENDOCRINOLOGY, 1992, 130 (03) : 1401 - 1412
  • [4] TRANSFORMING GROWTH-FACTOR-BETA GENE FAMILY MEMBERS AND BONE
    CENTRELLA, M
    HOROWITZ, MC
    WOZNEY, JM
    MCCARTHY, TL
    [J]. ENDOCRINE REVIEWS, 1994, 15 (01) : 27 - 39
  • [5] GLUCOCORTICOID MODULATION OF CELL-PROLIFERATION IN CULTURED OSTEOBLAST-LIKE BONE-CELLS - DIFFERENCES BETWEEN RAT AND MOUSE
    CHEN, TL
    CONE, CM
    FELDMAN, D
    [J]. ENDOCRINOLOGY, 1983, 112 (05) : 1739 - 1745
  • [6] TENASCIN INTERFERES WITH FIBRONECTIN ACTION
    CHIQUETEHRISMANN, R
    KALLA, P
    PEARSON, CA
    BECK, K
    CHIQUET, M
    [J]. CELL, 1988, 53 (03) : 383 - 390
  • [7] IDENTIFICATION OF ANDROGEN RECEPTORS IN NORMAL HUMAN OSTEOBLAST-LIKE CELLS
    COLVARD, DS
    ERIKSEN, EF
    KEETING, PE
    WILSON, EM
    LUBAHN, DB
    FRENCH, FS
    RIGGS, BL
    SPELSBERG, TC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (03) : 854 - 857
  • [8] DAVIES P, 1992, J MOL ENDOCRINOL, V5, P117
  • [9] TRANSCRIPTIONAL REPRESSION OF INSULIN-LIKE GROWTH-FACTOR-I BY GLUCOCORTICOIDS IN RAT BONE-CELLS
    DELANY, AM
    CANALIS, E
    [J]. ENDOCRINOLOGY, 1995, 136 (11) : 4776 - 4781
  • [10] THE STEROID AND THYROID-HORMONE RECEPTOR SUPERFAMILY
    EVANS, RM
    [J]. SCIENCE, 1988, 240 (4854) : 889 - 895